| NDC Code | 0093-1921-06 |
|---|
| Package Description | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-1921-06) |
|---|
| Product NDC | 0093-1921 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Cyclobenzaprine Hydrochloride |
|---|
| Non-Proprietary Name | Cyclobenzaprine Hydrochloride |
|---|
| Dosage Form | CAPSULE, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20190304 |
|---|
| Marketing Category Name | NDA AUTHORIZED GENERIC |
|---|
| Application Number | NDA021777 |
|---|
| Manufacturer | Teva Pharmaceuticals USA, Inc. |
|---|
| Substance Name | CYCLOBENZAPRINE HYDROCHLORIDE |
|---|
| Strength | 30 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
|---|